US Intel Report Links China's Biological Warfare Ambition To Covid | Lokmarg

US Intel Report Links China’s Biological Warfare Ambition To Covid

China had revealed its biological weapons ambitions long before the COVID-19 pandemic hit the world, according to a new US intelligence report.

On December 15, the House Intelligence Committee released a declassified report examining the Intelligence Community’s response to the COVID-19 pandemic following a two-year investigation.

The report examines the IC’s posture to support global health security policymakers, the IC’s performance in the early months of the COVID-19 pandemic, and the steps the IC must take to strengthen any future pandemic response.

“In 2005, the US State Department publicly stated the US assessment that China also operates an offensive biological weapons program, specifically identifying two Chinese entities as likely involved, one of which is the Fifth Institute. In a 2006 declaration of compliance with the Biological and Toxic Weapons Convention, China acknowledged that the Fifth Institute specifically researches SARS coronaviruses,” the report reads, as quoted by Indo-Pacific Centre for Strategic Communications.

The US Intelligence report also took note of the book titled “The Unnatural Origin of SARS and New Species of Artificial Humanized Viruses as Genetic Weapons,” released by AMMS in 2015.

“The book described how to create weaponized chimeric SARS coronaviruses, the potentially broader scope for their use compared to traditional bioweapons, and the benefits of being able to plausibly deny that such chimeric coronaviruses were artificially created rather than naturally occurring,” the report states.

Last week, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus called on China to share the data requested by the world health body to better understand the origin of the COVID-19 pandemic.

“Gaps in our understanding of post-COVID-19 conditions mean we don’t understand how best to treat people suffering from the long-term consequences of infection. Gaps in our understanding of how this pandemic began to compromise our ability to prevent future pandemics,” the WHO chief said during a weekly press conference.

“We continue to call on China to share the data and conduct the studies we have requested, and which we continue to request. As I have said many times before, all hypotheses about the origins of this pandemic remain on the table,” he added.

Tedros also expressed concern about the evolving situation in China, with increasing reports of severe disease.

Three years after its emergence in China’s Wuhan, exactly how SARS-CoV-2 first emerged as a respiratory pathogen capable of sustained human-to-human transmission remains the subject of active debate.

Experts have put forward two dominant theories on the origins of the virus. The first theory is that SARS-CoV-2 is the result of a natural zoonotic spillover. The second theory is that the virus infected humans as a consequence of a research-related incident. (ANI)

Read more: http://13.232.95.176/

COVID-19 vaccine

Mandaviya To Hold Meet On COVID-19 Situation

Union Health Minister Mansukh Mandaviya will hold a meeting with senior officials and experts on the COVID-19 situation in the country on Wednesday, said sources on Tuesday.

The physical meeting will start at 11:30, sources told ANI. He will also review meetings on Covid 19 situations in other countries.
ln view of the sudden spurt of cases being witnessed in Japan, USA, Korea, Brazil, and China, it is essential to gear up whole genome sequencing of positive case samples to track variants through the Indian SARS-CoV-2 Genomics Consortium (INSACOG) network, writes Union Health Secretary Rajesh Bhushan to States and Union Territories.

“All states are requested to ensure that as far as possible samples of all positive cases, on a daily basis, are sent to the designated INSACOG Genome Sequencing Laboratories (IGSLs) that are mapped to the States and UTs,” said Union Health Secretary.

Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.

However, the expert said that there is nothing to panic about as the country’s system is “vigilant”.

The remarks were made by Dr. NK Arora, Chairman of the COVID-19 working group NTAGI.

“It is an important thing that we keep a close vigil on the Chinese situation. But I would say that there is nothing to be panicked about. There is no need for getting too much worried. The system is very vigilant, we need to be very vigilant. As far as genomic surveillance is concerned, this is the most important part we are doing genomic surveillance of individuals with symptoms,” he said.

Exuding confidence in India’s preparedness to tackle the COVID situation, the expert said that the country can take appropriate action in case of the emergence of a new sub-variant.

“We are also doing surveillance from sewage and from hospitalized individuals and even those who are coming to international airports. A certain proportion of samples is picked up randomly from them also, in case there is a new sub-variant or anything, which is of concern is picked up promptly, appropriate action can be taken,” Dr. Arora said.

“So overall we find that the situation in India is under control. But we need to maintain vigilance, particularly for surveillance,” he added.

Dr. Arora also said that the exact situation of COVID in China is still unclear.

“China was following so-called Zero COVID policies and as we learn from media recently they have relaxed this policy and after that, we are hearing that there is widespread COVID infection in that community with associated severe disease and deaths also. But what is the exact situation we really do not know,” he said.

According to the expert, vaccination and hybrid immunity will be helpful in protecting people in India from COVID.

“As far as India is concerned, there are three or four things which we need to keep in mind. One is that India has an extensively immunized adult population, particularly with very effective vaccines. In addition, there are several data that indicate that over 90 percent of our individuals have also been affected by natural COVID infection. So, the Indian population is immunized with what we call hybrid immunity. Third thing is that the INSACOG data shows that almost every sub-variant of Omicron which is found anywhere else in the world is also found in India. So, there are not many sub-variants that are not circulating here,” an expert said.

Meanwhile, the last Covid-19 fatality in Beijing, which was seeing thousands of Covid positive cases before the revocation of the Zero Covid policy was on November 23.

After it, China stopped reporting asymptomatic patients which is a major part of the Covid tally. The country also scrapped the once common Polymerase Chain Reaction (PCR) testing apparatus and instead used rapid antigen kits which are known to be a little inaccurate. This pointed out that the data was altered or stood meaningless, according to The Straits Times. (ANI)

Read more: http://13.232.95.176/